Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Loop Electrosurgical Excision Procedure (LEEP) Market Growth (Status and Outlook) 2024-2030
... cervical cell changes (abnormal cells) or early stage cervical cancer, as well as to diagnose cervical cancer. The global Loop Electrosurgical Excision Procedure (LEEP) market size is projected to grow from US$ million in 2023 ... Read More
-
Targeted Cancer Therapeutics Market Size, Trends, Analysis, and Outlook By Therapy (Small Molecule Drugs, Monoclonal Antibodies, Immunotherapies, Others), By Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Blood Cancer, Gynecologic Cancer, Others), By End-User (Hospitals, Cancer and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Targeted Cancer Therapeutics market size is poised to register 6.6% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Viral Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Viral Vector Manufacturing market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Minimal Residual Disease Testing Market Size, Trends, Analysis, and Outlook By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Others), By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Others), By End-User (Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Minimal Residual Disease Testing market size is poised to register 14.8% growth from 2024 to 2032, presenting significant ... Read More
-
Vaccine Adjuvants Market Size, Trends, Analysis, and Outlook By Product (Adjuvant Emulsions, Pathogen Components, Saponin-based adjuvants, Particulate Adjuvants, Others), By Route of Administration (Intramuscular, Subcutaneous, Others), By Disease (Infectious Diseases, Cancer, Others), By Application (Research Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032
... Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032 The global Vaccine Adjuvants market size is poised to register 13.7% growth from 2024 to 2032, presenting significant ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Viral Vector and Plasmid ... Read More
-
Theranostics Market Size, Trends, Analysis, and Outlook By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), by Country, Segment, and Companies, 2024-2032
... and Academic Centers), by Country, Segment, and Companies, 2024-2032 The global Theranostics market size is poised to register 10.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Minimal Residual Disease Market Size, Trends, Analysis, and Outlook By Test, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Next Generation Sequencing (NGS)), By Detection Target (Leukemia, Lymphoma, Solid Tumors, Others), By End-User (Hospitals, Laboratory centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Minimal Residual Disease market size is poised to register 12.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the ... Read More
-
Fluorescent In Situ Hybridization Market Size, Trends, Analysis, and Outlook By Probe (Locus Specific Probes, Alphoid/Centromere Repeat Probes, Whole Chromosome Probes), By Application (Cancer Research, Genetic Diseases, Others), By End-User (Research Organizations, Clinical Organizations, Biotechnology Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032
... Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032 The global Fluorescent In Situ Hybridization market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Medical Nutrition Market, By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East ... Read More
-
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
... is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period. The rising prevalence of cancer and the growing use of ... Read More
-
Global Prostate Cancer Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Prostate Cancer Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Prostate Cancer Vaccines. The report also introduces players ... Read More
-
Global Soft Tissue Sarcoma Targeted Drugs Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of % from 2024 to 2030. LPI (LP Information)' newest research report, the “Soft Tissue Sarcoma Targeted Drugs Industry Forecast” looks at past sales and reviews total ... Read More
-
Peptide Synthesis: Global Markets
... news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period. The report will enable ... Read More
-
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. Prostate cancer is a type ... Read More
-
Metabolomics Market Report by Product (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Others), and Region 2024-2032
... and Region 2024-2032 The global metabolomics market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% ... Read More
-
Retinoblastoma Treatment Market Report by Type (Non-Hereditary Retinoblastoma, Hereditary Retinoblastoma), Treatment Type (Surgery, Radiation Therapy, Laser Therapy (Photocoagulation), Cryotherapy, Thermotherapy, Chemotherapy, Opthalmic Artery Infusion Chemotherapy, High-Dose Chemotherapy and Stem Cell Transplant), Type of Staging (Intraocular Retinoblastoma, Extraocular Retinoblastoma), Application (Hospitals, Cancer Institutes, and Others), and Region 2024-2032
... Retinoblastoma, Extraocular Retinoblastoma), Application (Hospitals, Cancer Institutes, and Others), and Region 2024-2032 The global retinoblastoma treatment market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 ... Read More
-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Facilities), and Region 2024-2032
... Facilities), and Region 2024-2032 The global autologous stem cell and non-stem cell based therapies market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.6 Billion by ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2024-2032
... Home Care), and Region 2024-2032 The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth ... Read More
-
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global oncology biosimilars market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion ... Read More
-
Companion Diagnostics Market By Product (Assays, Kits, Reagents, System, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious, Neurology), Sample Type (Tissue, Blood) & Region - Global Forecast to 2029
... 2029 The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6% during the forecast period. Factors such as the increasing ... Read More
-
Global chemotherapy-induced thrombocytopenia Market - 2023-2030
... forecast period 2023-2030. Chemotherapy-induced thrombocytopenia (CIT) is characterized by a decreased platelet count in the blood as a result of chemotherapy treatment. Because platelets are necessary for blood clotting, a drop in their number can ... Read More
-
2024 Global Cancer Supportive Care Drugs Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
Research Assistance
